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Obesity and its subsequent disease states are major health problems in the United
States. In many ways, obesity can be considered a “disease state” itself due to the
changes it causes on the body. High-intensity exercise also places acute stress the body,
putting humans in recovery from exercise in a state that may be analogous to a temporary
disease state. The purpose of this study was to examine biomarkers associated with
obesity (CRP and Leptin) before and after continuous and intermittent bouts of exercise
in an obese but otherwise healthy sample vs. a healthy, non-obese sample. This
investigation focused on examining the obese sample’s biomarkers at rest compared to
those of the healthy group immediately and 1 hour-post exercise. Eighteen male subjects
participated, with nine in each group. Each subject performed a VO2 max test and a series
of three anaerobic Wingate tests at least one week apart in a cross-over study design.
Blood was taken at baseline, immediately-post, and 1-hour post for each exercise mode.
A significant difference was noted between groups for CRP at baseline on the VO2
testing day. A significant difference between groups existed in leptin levels at baseline on
both testing days. The only significant change was the decrease in leptin from post to 1hour post for during the VO2 in the obese group. However, both exercise protocols
demonstrated various effects on the subjects and groups. Healthy participants were
examined individually, and two of them showed possible signs of being at risk for obesity
and its subsequent disease states based on post exercise “spikes” in CRP and leptin that

vi

caused the levels of the biomarkers to be closer to those in the obese group at rest.
Another three subjects saw at least two spikes. Thus, a total of five subjects could
potentially be “at-risk” based on the assumptions of the present study. These results
suggest CRP and Leptin could potentially hold the ability to classify someone in a “preobesity state.” Further investigations are warranted based on these initial results and
should focus on biomarkers more specific to obesity.
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CHAPTER 1
INTRODUCTION
Obesity is defined as a condition of increased adipose tissue mass resulting in an
increase in body weight beyond the limits of physical requirement (Sikaris, 2004).
Fundamentally, obesity is the result of excess energy intake compared to energy
expenditure (Sikaris, 2004). The World Health Organization defines obesity as a body
mass index of greater than or equal to 30 kg/m2 (1985).
It is estimated that 32 percent of adults in the US are clinically obese (Ogden,
2006). When examining mortality data from the National Health and Nutrition
Examination Survey (NHANES) 2000, death rates were significantly lower for those who
had a healthy body mass index when compared with the obese population (Flegal et al.
2005). A study by Alison et al. concluded that the estimated number of annual deaths
attributable to obesity among US adults is approximately 325,000 from all subjects and
280,000 from only nonsmokers and never-smokers (1999). Researchers claim that
increased mortality attributed to obesity results partly from the increased risk of chronic
diseases such as cardiovascular disease, diabetes mellitus, dyslipidemia, and hypertension
(Bakhai, 2008). Obesity also promotes a state of low-level systemic chronic inflammation
and a prothrombic state, both of which can lead to atherosclerosis and subsequent
cardiovascular events (Bakhai, 2008). It has been shown that cardiovascular disease
remains a leading cause of death outside of the US as well, accounting for 37% of deaths
in the United Kingdom (Deaths by Cause, Sex, and Age, 2004). From examining the
literature, it is apparent that obesity is a major health problem in the United States
claiming many lives each year.
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Obesity is clearly a major issue due to the subsequent disease states with which it
is associated. In many ways, obesity is considered a “disease state” itself due to the
changes it causes on the body as well as increasing the risk for a large number of
additional diseases. Excess fat accumulation is associated with inflammatory changes as
well as increased oxidative stress (Musaad and Haynes, 2007). There are a multitude of
biomarkers that can be measured in human blood that are indicative of inflammatory
changes and/or oxidative stress. Therefore, these biomarkers also possess possible links
to obesity. By identifying these biomarkers for oxidative stress and inflammation, the
potential exists that they could be used for early prediction of cardiovascular disease
(Musaad and Haynes, 2007). Two biomarkers that have been supported by research to
have a clear link to obesity are leptin and c-reactive protein (CRP) (Mussad and Haynes,
2007). Due to their potential clinical utility and connection to obesity, these biomarkers
possess the potential to aid in classifying seemingly healthy individuals into a “preobesity state.”
Leptin is an adipocytokine released from adipose tissues that plays a large role in
the negative feeback loop that controls hunger. Ultimately, leptin aids in the regulation of
body weight homeostasis (Thong et al. 2000). Leptin is also found in the hypothalamus
of the brain, which is involved in the regulation of body weight (Eikelis et al. 2004). A
study by Shutte et al. demonstrated that leptin is closely associated with obesity and risk
factors for cardiovascular disease such as increase systolic blood pressure (2005). One
mechanism by which leptin can increase cardiovascular disease risk is via increased
inflammatory markers, and it plays a role in vascular dysfunction. It may also “tell”
one’s body that there is not enough fat, thus, producing more in response, thus, increasing
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risk for diseases. Two studies by S. Soderberg demonstrated its direct association with
both stroke and acute myocardial infarction (1999). The research clearly supports the idea
that leptin has links to the disease state of obesity and other subsequent disease states,
thus, unlocking the potential to make future health predictions about these ailments.
C-reactive protein is the most extensively studied inflammatory biomarker
(Nguyen et al. 2009). It is a protein produced by hepatocytes in the presence of
inflammation due to factors such as infection, injury, or conditions such as obesity.
Elevated levels of CRP have been associated with increased inflammation in the coronary
arteries, and thus it is marker for increased risk of atherosclerosis and cardiovascular
disease (Nyguyen et al. 2009). Studies using NHANES III data have shown that levels of
CRP are elevated in individuals with a high BMI (Ford 1999, Visser 1999). Nguyen’s
study found that with each increase in weight category, the mean CRP level increased
significantly. The higher the weight class on the BMI scale (obesity class 1, obesity class
2, etc…), the larger the increase in CRP. The largest amount of CRP concentration was
reported in individuals in obesity class three (2009). CRP increases with increased body
fat, and the more CRP one possesses, the greater likelihood of many diseases.
There is a great deal of literature on obesity, its associated disease states, and its
biomarkers. The obesity epidemic is a very real and serious problem in the United States.
Although there is an abundance of research on obesity, many neglect to look at the
underlying biomarkers. The possibility exists that we look at the mentioned biomarkers
(among others) to ultimately predict one’s risk for obesity before they are even
overweight. The reasoning behind this logic is that if obesity is considered a “disease
state” where one’s body is being stressed, and exercise is another means of stressing your
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body, there could be biochemical similarities in someone who is clinically obese (but
otherwise healthy) at rest and a seemingly healthy person who is in recovery from intense
continuous or intermittent exercise. If there are similarities in these biomarkers, further
research could show that this is a means to predict obesity and other disease states, and
could ultimately aid in prevention of these health issues.
Statement of Purpose
Both CRP and Leptin are closely associated with obesity and other subsequent
disease states. Considering this, it is already known that being “obese” basically means
that one is constantly in what researchers consider a “disease state.” Then, consider a
healthy individual who is recovering from an acute bout of aerobic exercise. For that
brief recovery period, they are in a state that could be considered analogous to being in a
disease state, where their body is trying to return to homeostasis. The idea behind this
study is to examine these biomarkers before and after an aerobic bout of exercise in the
obese but otherwise healthy population and a healthy population. It will be interesting to
see the differences at rest, but that has been explored before. However, no previous
studies have compared the biomarkers in a healthy person’s blood when recovering from
exercise to an obese person’s biomarkers at rest. If we can find similarities in the two, it
is possible to suggest that we could predict obesity or other disease states based on these
markers. We could then suggest that even though someone is seemingly thin and healthy,
that they are in a “pre-obesity” state. This knowledge, once further investigated, could
allow a simple finger prick to do the job of an extensive health exam. It may also be
helpful in predicting the likelihood of obesity and other subsequent disease states.
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Statement of Hypothesis
RESTING LEVELS
Ho1: There will be no difference in resting leptin and CRP plasma concentration between
those who are obese but otherwise healthy and those who are non-obese healthy.
Ha1: Resting plasma concentrations of Leptin and CRP will be elevated in obese but
otherwise healthy individuals compared to healthy non-obese individuals.
LEPTIN
Ho2: There will be no notable similarities between the amount of leptin in the obese at
rest and the biomarkers of the healthy after an acute aerobic exercise session.
Ha2: There will be notable similarities in the amount of leptin in the obese at rest and the
leptin levels in the healthy person after an acute aerobic exercise session.
CRP
Ho3: There will be no notable similarities between the amount of CRP in the obese at rest
and the biomarkers of the healthy after an acute aerobic exercise session.
Ha3: There will be notable similarities in the amount of CRP in the obese at rest and the
CRP levels in the healthy person after an acute aerobic exercise session.

Definition of Terms
•

Biomarkers- A biochemical feature or facet that can be used to measure the
progress of disease or the effects of treatment. They are generally found in the
blood.

•

Adipoctyokines- class of protein that synthesize and secrete numerous enzymes,
growth factors, cytokines, and hormones that are involved in overall energy
5

homeostasis, specifically lipid homeostasis. These are released from adipose
tissues.
•

Cardiovascular disease- Disease affecting the heart or blood vessels. These
include arteriosclerosis, coronary artery disease, heart valve disease, arrhythmia,
and heart failure.

•

Atherosclerosis- A process of progressive thickening and hardening of the walls
of medium-sized and large arteries as a result of fat deposits on their inner lining.
Risk factors for atherosclerosis include high levels of "bad" cholesterol, high
blood pressure (hypertension), smoking, diabetes and a genetic family history of
atherosclerotic disease.

•

Dislipidemia- A disorder of lipoprotein metabolism, including lipoprotein
overproduction or deficiency. Dislipidemias may be manifested by elevation of
the total cholesterol, the "bad" low-density lipoprotein (LDL) cholesterol and the
triglyceride concentrations, and a decrease in the "good" high-density lipoprotein
(HDL) cholesterol concentration in the blood.

•

Insulin Resistance- Insulin resistance is a condition in which the cells of the body
become resistant to the effects of insulin. It is often the result of being diabetic,
and the body can’t get glucose into the cell’s properly because of this insulin
resistance.

•

Inflammation- A basic way in which the body reacts to infection, irritation or
other injury, the key feature being redness, warmth, swelling and pain.
Inflammation is now recognized as a type of nonspecific immune response.
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•

Oxidative Stress- general term used to describe the steady state level of oxidative
damage in a cell, tissue, or organ, caused by free radicals and peroxides.

•

Hypertension- High blood pressure means high tension in the arteries. Arteries are
vessels that carry blood from the pumping heart to all the tissues and organs of the
body. A blood pressure of 140/90 or above is considered high.

•

Myocardial infarction (heart attack)- The death of heart muscle from the sudden
blockage of a coronary artery by a blood clot.

•

Leptin: protein hormone released from adipose tissues and plays a large role in
the negative feedback loop that controls hunger. It often signals the brain that one
does not have enough fat, thus, causing more to be produced.

•

C-Reactive Protein (CRP): inflammatory biomarker produced in the presence of
inflammation due to factors such as infection, injury, or conditions such as
obesity.
Limitations

•

Recruited subjects who are “fat but fit”- A BMI of >30kg/m2 but with no other
health issues or risk factors (insulin resistance, high cholesterol, etc…)

•

Only tested men, so can’t generalize the results for everyone

•

Some people likely pushed themselves harder than others on both of the tests, so
that may have caused some of the data to not be as useful

•

The challenge of putting obese people through very strenuous aerobic exercise
could have caused them to have to end tests prematurely

•

Human error

•

Sweat mixed with blood
7

•

Previous exercise training could have skewed the results

•

Our subjects did not perform a 12 hr fast before baseline testing (only asked not
eat for 4 hours before exercise)

•

Limitations associated with individual kits/processes in doing blood work

•

Much of the study was based on assumptions

•

Time constraints
Delimitations

•

There were 9 healthy males between 18-44 who have no preexisting medical
conditions or cardiovascular risk factors to make up the “healthy” group

•

There were 9 males who are “fat but fit”- meaning they have a BMI over 30kg/m2
but have no other health conditions or risk factors- This will be identified using
the ACSM risk stratification questionnaire

•

Both groups completed a continuous and intermittent exercise session

•

Both groups had BMI calculated

•

Both groups had body fat percentage measured via seven-site skinfold protocol

•

Subjects were matched for height and fitness level as best as possible

•

The aerobic session consisted of a VO2 max test where they ran on a treadmill
with increasing speeds and grades until they couldn’t go anymore. They will
follow the Bruce Protocol. This test gave us a VO2 max for each subject

•

The anaerobic session consisted of three repeated Wingate cycling tests with 2
minutes in between each 30 second bout. We calculated 7.5% of their body
weight in kilograms prior to the start of the test. They pedaled as fast as they
could for about 10 seconds, and then 7.5% of their body weight was dropped on
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the flywheel. They then pedaled as hard as they could for 30 seconds. Peak and
mean power output were then able to be calculated.
•

The two sessions were separated by at least a week, but not more than 10 days

•

Before each test (aerobic and anaerobic) blood was taken to get a resting
measurement

•

Blood was taken again immediately at the cession of the exercise session and then
again one hour post exercise

•

The blood was analyzed using ELISA kits and a microtiter plate reader

•

With the VO2 max test, an oxygen mask was put on the subject and their oxygen,
carbon dioxide, and RER levels were monitored using a metabolic cart (True One
2400, Parvomedics True One Metabolic System, Sandy, Utah)
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CHAPTER 2
REVIEW OF LITERATURE
Obesity is a worldwide epidemic that has been the foundation of a great deal of
research in recent years. This is likely due to the fact that obesity has become a much
more significant issue in the past several decades, due to it beening linked to a large
number of disease states and conditions. A large number of studies have also investigated
causes of obesity, and whether it is more related to environmental or genetic influences.
With this in mind, biochemists have taken quite an interest in obesity and investigate the
biochemical changes as a result of obesity, as well as conditions that could contribute to
obesity. They refer to many of the items they investigate as biomarkers. The present
study will focus on two biomarkers; c-reactive protein and leptin. These are related to
obesity and its subsequent disease states, and they may have the potential to be used as
powerful diagnostic tools.
Another recent addition to the literature is the notion of being “fat but fit,” which
has garnered a fair amount of attention in the last few years. This is significant to the
present study in that half of our subjects will ultimately fall into the criteria of being “fat
but fit.
C-Reactive Protein
A review article by Musaad (2007) discusses obesity as a risk factor for cardiovascular
diseases as well as its increased prevalence in society. Although the association between
obesity and cardiovascular disease risk has been well-established, the mechanisms
causing this increased risk are less well-characterized. Inflammation and increased
oxidative stress are two potential explanations that could play a major role. Studies have
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investigated these two conditions and have found that they both rely on biomarkers.
However, validated biomarkers for obesity-related cardiovascular outcomes are still a bit
unclear. By finding optimal biomarkers, diagnostic criteria for cardiovascular diseases
can be refined in the obese population outside of the ‘traditional’ risk factors to identify
early pathologic processes. The objective of this review was to identify potential early
biomarkers that increase in response to obesity and are associated with cardiovascular
disease. Results of this meta-analysis revealed a large number of obesity-related
biomarkers that have potential to correlate with cardiovascular disease risk factors or
prediction of subsequent cardiovascular events. Another aim of this review was to assess
which biomarkers warrant further investigation and eventual clinical use for predicting
cardiovascular disease.
Park conducted a study to explore the relationship between obesity and visceral
adiposity with amounts of CRP, IL-6, and TNF-α in the blood (2005). Based on previous
research, these three biomarkers appear to play an important role in the development of
cardiovascular disease and diabetes mellitus. In certain populations, it has also been noted
that CRP levels may very based on ethnic background. Considering that, Asians body
mass index is lower than the BMI shown in Western populations, however, they tend to
have larger amounts of viscerally located fat. Previous studies had not looked at the
relationship between IL-6 and CRP, while also exploring their correlation to body fat
distributions in Asian populations. Park had 46 obese and 54 non-obese subjects from
ages 20-60. Of their 100 subjects, 70 were females and 30 were males. They were all
subjected to a medical evaluation and were excluded for a variety of reasons. All
participants had height and weight measurements taken, as well as waist and hip
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circumference. Blood was taken and commercial ELISA kits were used to measure serum
levels of TNF-α, CRP and IL-6. Body fat mass was measured by bioimpedance analysis
and cross-sectional abdominal visceral and subcutaneous adipose tissues were measured
by computed tomography. From this, area of total adipose tissue, area of abdominal
visceral adipose tissue, area of subcutaneous adipose tissue, and visceral to subcutaneous
fat ratios were calculated. Statistical analysis used were student’s t-test, Wilcoxon’s rank
sum test, Spearman’s correlation coefficients, and Stepwise multiple regression analysis.
The p-value was accepted at <0.05. The median concentrations of CRP, TNF-α, and IL-6
were all significantly higher in the obese group when compared to the non-obese group.
CRP, TNF-α and IL-6 concentrations were all significantly correlated with weight, BMI,
waist circumference, hip circumference and waist hip ratio. CRP showed the strongest
association with all anthropometric measurements. CRP concentration was significantly
correlated with BMI, whereas IL-6 concentration was significantly correlated with
visceral adipose tissue in these obese subjects. These results may be related to the finding
that adipose tissue is a dynamic endocrine organ that secretes a number of factors that
contribute to systemic inflammation, which is commonly caused by being obese. Their
finding of a significant association between CRP and BMI is in agreement with previous
results showing that BMI was the adiposity parameter most strongly correlated with CRP
concentration. The previous studies were not performed on Asians, though they elicited
the same results as the present study. This study aids in solidifying the notion that CRP
and IL-6 have a strong connection with obesity and its subsequent disease states,
especially when the excess adipose tissue is located in the midsection. Its practical
significance is basically that decreasing obesity and visceral adiposity may prevent the
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elevation of cytokine levels, which in turn may prevent the development of
atherosclerosis.
Nguyen discusses obesity and its link to chronic inflammation, which may be
connected to the increased rates of metabolic syndrome, cardiovascular disease, and
cancer in obese individuals (2009). With inflammation, certain biomarkers have a
tendency to show up in the blood, with C-Reactive Protein (CRP) being the most
extensively studied inflammatory biomarker. The purpose of the study was to examine
the relationship between obesity class and levels of the inflammatory biomarker CRP.
The question they were seeking to answer was if one carries more body fat, will they
possess higher levels of CRP as well? Will CRP continue to increase as obesity level
rises? Examining CRP more extensively holds the potential to unlock some of the
underlying causes of obesity. They also have the potential to become obesity predictors
with further research. This study used NHANES data from 1999 to 2004, which is
conducted by the National Center for Health Statistics. It provided cross-sectional health
and nutrition data for the US population. They used a sample of about 5000 people across
15 counties. It includes an extensive health information interview, a complete physical
exam, and extensive laboratory testing, all performed in different testing centers around
the country. Additional information was collected during an in-home interview and
subsequent medical examination at a mobile exam center. There, blood pressure, height,
weight, and lipid profiles were taken. They used standards by the National Heart, Lung,
and Blood Institute to define overweight and obesity. Blood was also taken here to get
CRP levels, as well as several other inflammatory biomarkers. The final amount of
people after some exclusions were made was 13, 361. Linear regression models were
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used to assess the association between obesity class and CRP levels. They adjusted the
regression model for age, race, gender, systolic blood pressure, presence of arthritis,
smoking status, and alcohol consumption. The results of the study revealed that there was
a positive association between each of the BMI levels and CRP levels. The strongest
association between obesity and change in biomarker concentration (CRP) was among
individuals in obesity class III. As BMI rose, CRP levels rose as well. Tests revealed that
the overall increasing change in CRP concentrations was statistically significant. They
also found that individuals with diabetes had higher mean CRP levels than those without
diabetes, even when stratified by BMI. Similarly, they found that people with
hypertension also had higher mean levels of CRP compared to their non-hypertensive
counterparts when stratified with BMI. Their findings suggest that the increasing severity
of obesity is associated with increased risk for diabetes. These results also support the
idea that inflammation potentially plays a role in developing insulin resistance.
Inflammation in those who suffer from obesity is believed to arise primarily in adipose
tissue as a result of chronic disruption of metabolic homeostasis, which leads to the
activation of inflammatory signaling, thus, increasing inflammatory biomarkers such as
CRP.
Lieb studied obesity and its genetic component (2008). It is known that parental
obesity increases their offspring’s risk for becoming an obese adult, however, little
research has been conducted to see if parental-obesity increases risk for other obesityassociated conditions, such as a proinflammatory or prothrombic state in the absence of
offspring obesity. The study incorporates the idea that when obese, one experiences a
state of chronic inflammation, thus, inflammatory biomarkers such C-reactive protein
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(CRP) are typically elevated. Lieb’s research question is asked if these biomarkers will
see increases in offspring who are at high-risk for obesity based on their parents being
obese, but who are not actually considered obese. He wondered if their increased risk for
obesity causes an altered biomarker profile. Considering that, the purpose of the study
was to examine CRP levels in non-obese at-risk (for obesity) offspring and non-obese
offspring with no parental obesity and see if there was a significant difference. Lieb’s
hypothesis was that the offspring with at least 1 obese parent will have increased levels of
CRP. Participants in the study (N=1272) were non-obese (BMI<30kg/m2) offspring who
were free of cardiovascular disease and had both biological parents included in the
Framingham Heart study done previously. They underwent a physical examination, body
composition measurement (via skinfolds), laboratory assessment of cardiovascular risk
factors, and a medical history every four years. On these visits, blood was also taken and
seven biomarkers that had been previously associated with obesity or obesity-related
ailments were analyzed using blood assay kits. However, the main biomarker
investigated was CRP. Levels of biomarkers were compared between the offspring and
their parents using generalized estimating equation models adjusting for relevant
covariates among offspring. Parental obesity was defined as BMI ≥30kg/m2 at any time
of the course of their life as determined by examinations during the Framingham Heart
Study. Parental obesity was used as a categorical variable with 0 meaning no obese
parents, 2 meaning 2 obese parents, and 1 representing one obese parent. The group with
0 obese parents served as the referent group. For predicting offspring obesity, clinical
covariates and parental obesity, clinical covariates and biomarkers, and clinical
covariates, parental obesity, and any biomarker related to both parental obesity in the
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primary analysis and offspring BMI. Lieb found that CRP demonstrated a nonlinear
association with parental obesity status. Offspring with two obese parents displayed
higher CRP levels than the reference group. Offspring with a single obese parent did not
have higher CRP levels than the reference group. They found no significant difference
between the mother or father being the obese parent. The other systemic biomarkers did
not vary according to parental obesity. These findings indicate that parental obesity may
create a risk for an inflammatory state, thus increasing CRP levels, even in non-obese
offspring. Overall, the key finding was simply that when an offspring has two obese
parents, they are likely to have elevated CRP levels even if they are not
overweight/obese. Their biomarker profile is altered. This is consistent with previous
literature in saying that parents transmit a susceptibility predisposing their kids to
systemic inflammation that can be detected even in the absence or before the
development of obesity.
Visser explored how adipose tissue has been shown to play an active role in one’s
metabolism(1999). Adipose tissue is estimated to produce about 25% of the IL-6 in
human systems. Studies have shown that IL-6 may induce low-grade systemic
inflammation in people with excess body fat. When inflammation occurs, C-reactive
protein levels typically become elevated. High levels of CRP have been linked to
predicting future risk of coronary heart disease. The aim of this study was to test whether
overweight and obesity are associated with low-grade systemic inflammation as
measured by CRP concentration. This study included 16616 adults who took the
NHANES III survey and fit their inclusion criteria. Body weight and height were
measured using standard procedures, and BMI was then calculated. They also took
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measurements and found their waist-hip ratio, another method of determining obesity.
These individuals also had blood taken and assays were used to measure serum CRP
levels. They then divided the subjects into two groups based on CRP concentration;
undetectable (less than 22 mg/dL) and elevated (greater than 22 mg/dL). They found that
with increasing BMI, the prevalence of elevated CRP level increased in both men and
women. However, they found that with increasing BMI, the prevalence of clinically
raised CRP level increased among women only. Obese men were 2.13 times more likely
and obese women were 6.21 times more likely to have elevated CRP levels when
compared with their normal-weight counterparts. The higher prevalence in this category
for women could be attributed to the fact that women are more likely to be extremely
obese (BMI over 35). Overall, they found that a positive association between body mass
index and CRP levels and it remained statistically significant when adjusted for age,
smoking status, and waist-to-hip ratio.
C-reactive protein has been shown to rise dramatically in response to infection,
inflammation, and injury (Ford, 1999). The aim of Ford’s study was to examine the
association between C-reactive protein and BMI and diabetes among a large population.
The study had 16, 573 participants, all of which were older than 20 years old. Participants
came in for an examination session and a fasting blood sample was taken from each.
Height and weight measurements were also taken, and BMI was then calculated. People
with underlying conditions were eliminated from the study. Ford found a very strong
correlation between elevated c-reactive protein levels and body mass index. The study
also determined that CRP was lowest among those who did not have diabetes, somewhat
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higher in those who had impaired fasting glucose, and were highest among those with
diagnosed diabetes.
Based on the literature, it becomes clear there is a positive association between
BMI and CRP. Considering this, it has been used in some clinical settings as a diagnostic
tool. In recent years, it has been investigated as a way to predict a higher risk for future
cardiovascular disease. C-Reactive Protein is the most extensively studied inflammatory
biomarker and is often produced in response to being obese. Elevated levels of CRP have
been associated with increased inflammation in the arteries, therefore, it increases the risk
of atherosclerosis and cardiovascular disease. A genetic link has also been shown
between CRP levels in parents and children. This information is unique because it is one
of the few studies that examines at CRP levels in nonobese individuals and testing to see
if they have more of it, based on genetics and a possible increased risk for developing
obesity. This is a very similar idea to what I want to investigate in my study. Previous
research is saying that these nonobese offspring have an increased risk for developing
obesity based on their parents and higher levels of CRP (Lieb, 2008). CRP is clearly a
good biomarker to use in possibly predicting one’s risk for becoming obese.
Leptin
Thong and Hudson conducted a studying dealing with leptin (2000). The purpose
of their study was to examine the effects of diet and exercise on plasma leptin levels in
moderately obese men in the presence or absence of weight loss. Fifty-two sedentary
males with upper body obesity participated in this study. The study took place over a 12
week period. They were all put on a diet of 55-60% carbohydrates, 15-20% protein, and
20-25% fat. They were also asked to keep detailed food records. VO2 max was assessed
with a graded exercise test on a treadmill. The exercise program consisted of brisk
18

walking or jogging on a treadmill everyday for 12 weeks. The duration of the session was
determined by how long it took to burn 700kcal at an intensity no more than 75% of their
respective VO2 max. Energy expenditure was determined by heart rate. Blood samples
were taken before and after the 12 week program. Results demonstrated significant
reductions in plasma leptin after weight loss from dieting and exercising. This reduction
in circulating leptin was associated with a reduction in subcutaneous adipose tissue.
This study helps solidify the idea that leptin is a biomarker very closely linked with
obesity, which is why I are including it in my study.
Leptin is involved in the regulation of body weight and metabolism,
according to a study by Soderberg (1999). The aim of this case-reference study was to
examine the extent to which leptin alone, or in combination with other risk factors, may
be an independent risk marker for first ever myocardial infarction in a region with a high
incidence of cardiovascular disease. Population-based surveys were performed in 1986,
1990, and 1994 in the northernmost counties in Sweden with a total population of
510,000. The age group was both women and men between ages 25-64 and were
selected by stratified randomization for age and sex. Participants in the survey were asked
to give a fasting blood sample. The people that had donated blood and completed the
survey were kept track of and all cases of an acute myocardial infarction were to be
reported. Subjects also had weight, height, cholesterol, and blood pressure measurements
taken to match subjects in order to keep from skewing results. Once the study was
complete, 62 men qualified for being included in the data for the study after having a first
time acute myocardial infarction. The results demonstrated that patients who had an acute
myocardial infarction had a higher BMI and blood pressure and were more often smokers
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than their matched referents. Nonsmoking acute myocardial infarction cases had
significantly higher leptin levels. High levels of leptin were associated with high BMI,
high blood pressure, and high levels on insulin. They concluded that circulating levels of
leptin were found to be significantly associated with established cardiovascular risk
factors such as elevated blood pressure and obesity. High leptin levels were discussed to
be a predictor for the future risk of acute myocardial infarction after being adjusted for a
number of cardiovascular risk factors.
High leptin levels are often observed in human obesity and suspected to play a
role in obesity-related hypertension (Shutte, 2005). The aim of the study was to examine
effects of leptin on cardiovascular function in African women. Schutte hypothesized that
leptin would be directly associated with blood pressure and decreased arterial
compliance, and that leptin levels would be significantly higher in hypertensive
overweight or obese African women compared to overweight or obese African women
with normal blood pressure levels. Ninety-eight Africans were included in this case–case
control study. They were divided into lean groups as follows: lean with normal blood
pressure, overweight/obese with normal blood pressure, and overweight/obese with
hypertension. The Finometer apparatus was used to obtain an elaborate cardiovascular
profile. Serum leptin and insulin levels were determined by a blood sample. Additional
various anthropometric measures were also obtained. The results showed that leptin
levels were elevated in the overweight/obese normal blood pressure and hypertensive
groups compared to the lean with normal blood pressure group, but were similar in the
overweight/obese non-hypertensive and hypertensive groups. After adjusting for obesity,
insulin resistance and age, a direct positive correlation was shown between leptin and
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systolic blood pressure. Additionally, leptin also correlated negatively with arterial
compliance. The less arterial compliance one has, the less stretch can be produced in the
arteries, causing a possible increase in blood pressure.
Leptin has many links to obesity and myocardial infarction risk, therefore, it is a
very useful biomarker in the present study. The Schutte study is unique in that it relates to
what I will be investigating more directly than many of the other previously mentioned
articles in the way that it differentiates between people who are overweight/obese but
have high blood pressure and those who are overweight/obese and have normal blood
pressure. The obese subjects to be used in our study will also have a normal blood
pressure. However, in this study, this group still had correlations to elevated leptin, which
is what we were expecting to find.
In addition to examining leptin and its association to obesity and disease states,
the present study also aims to see what will happen to leptin after an acute exercise
session. In a study by Fisher (2001), the effect that an acute exercise session had on
serum leptin levels was measured. Eight young, lean, nonsmoking male subjects
participated in the study. On two occasions, separated by 1-2 weeks, participants came to
the lab early in the morning after fasting the night before. They were given a 5 minute
warm up, then cycled at a power output equivalent to 85% of their VO2 max for 5
minutes, which was followed by a 3 min recovery at 50% of their max. This was repeated
3 more times (a total of 4 work periods and 4 recovery periods). Blood samples were
taken before, after each 5 min work period, immediately after the last recovery period,
and during 60, 90, 120, 240 min of recovery. Immunoassay kits were used to measure
leptin concentrations. They found that serum leptin levels decreased immediately after
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exercise and returned to baseline by 240 min post-exercise. It was also noted in the study
that this is contrary to what many other studies have found. Many studies suggest that
exercise has no acute effect on leptin.
Sikaris discusses how obesity is the excessive accumulation of adipose tissue
leading to an increase of body weight beyond the limits of physical requirement (2004).
The article also discusses how widespread of a problem obesity is becoming, even in
children. With the variations of obesity numbers varying from country to country, it does
become obvious there are some environmental influences. At the same time, a great deal
of research has shown a strong genetic link to obesity. For example, twin studies have
shown important (up to 75%) genetic explanation to BMI. This is relevant because if
carrying extra weight is mostly genetic, then can one predict the likilhood of becoming
fat? This is a question that can possibly be answered by looking at some of the
biomarkers mentioned in the remainder of the review. The first biomarker Sikaris
discusses is leptin. Leptin is secreted from adipocytes into circulation, and obesity is
usually accompanied by high leptin levels. Fat mass is the primary determinant of serum
leptin levels in humans, with a higher fat mass resulting in higher amounts of leptin.
Musaad also looked at studies involving Leptin (2007). Leptin has been shown to
have a close association with obesity as well as risk factors for cardiovascular disease.
One such cardiovascular disease risk factor that has been shown to correlate with leptin is
increased systolic blood pressure. One mechanism by which leptin can increase risk for
cardiovascular disease is via increased production of inflammatory makers, such as CRP.
It also plays a role in vascular dysfunction. A link between leptin and cardiovascular
disease has been directly demonstrated in its independent association with stroke and
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myocardial infarction. Leptin is a biomarker that Musaad suggest has “good clinical
utility.”Overall, this review found that biomarkers associated with obesity may prove
very useful for early identification of susceptible individuals.
Fontana of Washington University conducted a study exploring fat adipokine
secretion is associated with systemic inflammation in obese humans (2007). Excessive
visceral fat has been associated with insulin resistance and diabetes. Along with this,
waist circumference, which correlates with visceral fat mass, has been recommended as a
clinical marker to identify patients at increased risk for metabolic diseases with large
waist circumference being one of the criteria used to diagnose the metabolic syndrome.
However, the mechanisms responsible for the relationship between visceral fat and
metabolic abnormalities are not known, and it is not clear whether visceral fat is simply
associated with or actually causes metabolic disease. Visceral fat could cause metabolic
abnormalities by secreting inflammatory adipokines, such as interleukin (IL-6), tumor
necrosis factor-α(TNF-α), and leptin, which have been shown to induce insulin resistance
and diabetes .The purpose of this study was to evaluate the relative contribution of
inflammatory adipokines (IL-6, TNF-α, and leptin) from visceral fat in insulin-resistant
subjects with abdominal obesity. They also posed the question, “Will there be more
adipokines in the portal vein or the peripheral artery?” They had 25 subjects with class III
upper-body obesity (average BMI was 54.7 and average waist circumference 150cm).
They had 6 males and 19 females with an average age of 42 years take part in the study.
All participants were previously scheduled to undergo gastric bypass surgery and had a
history of type II diabetes or high homeostasis model (HOMA) assessment score. All
surgeries were performed in the morning after overnight fasting. Blood samples were

23

obtained during the surgery simultaneously from the radial artery and hepatic portal vein
before gastric stapling or intestinal resectioning was initiated. Commercial ELISA kits
were used to measure CRP, and Leptin concentration was measured with immunoassay
kits. Statistical analysis used included Student’s Paired T-tests , Wilicoxon two-sample
test for variables, and Pearson correlation coefficients. They concluded that mean plasma
insulin concentration was more than twofold greater in the portal vein than in the
peripheral artery. Plasma leptin was about 20% lower in the portal vein then the
peripheral artery. They also noted that portal vein IL-6 was correlated directly to arterial
CRP concentration. These results suggest that visceral fat is an important source of
biomarker production in obese people, as well as provide the first evidence of a potential
mechanistic link between visceral fat mass and systemic inflammation in human subjects.
Fat but Fit
Blair deals with the “Fat but Fit” notion, which is a topic that he has been the key
researcher on from the time it emerged in research (1989). The purpose of this study was
to report all-cause mortality in relation to physical fitness categories. There were a total
of 13334 participants, 10224 men and 3120 women in this study. There were given a full
medical exam at the Cooper Institute it Dallas, TX and asked to run on a treadmill at 85%
of their age-predicted max heart rate. If they could not complete this task, they were
excluded from the study under the assumption that there may be an underlying condition.
Physical Fitness level was then found using a treadmill max test. The follow-up was
approximately eight years later for each participant. There were 240 deaths in men and 43
deaths in women. Lower mortality rates were found in higher fitness levels for cancer of
numerous sites and cardiovascular disease. Higher levels of physical fitness appeared to
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decrease all-cause mortality rates primarily due to the lowered risk of cardiovascular
disease and cancer. Blair found his results to not be confounded by age or other risk
factors, such as obesity. With that being said, this supports Blair’s idea about being “fat
but fit.” He argues that one can be overweight, obese in fact, yet still be physically fit,
and therefore, have less of a chance of dying from cardiovascular disease and cancer.
The purpose of Dubose’s study was to look at the influence of aerobic fitness and
BMI on the metabolic syndrome score in children (2007). Metabolic syndrome occurs
when one has a number of specific cardiovascular disease risk factors, including high
blood pressure, dyslipidemia, insulin resistance, and central obesity. A total of 375
children (193 girls and 182 boys) between the ages of 7 and 9 years old were included in
the study. They were categorized as being normal weight, at risk for overweight, and
overweight on the basis of BMI and aerobic fitness . The aerobic fitness test was a
submaximal physical working capacity test on a cycle ergometer. Participants were
placed into six BMI fitness categories. High-density lipoprotein cholesterol and
triglyceride levels, insulin resistance measurements, mean arterial pressure, and waist
circumference were used to create a metabolic syndrome score. They found that both
BMI and fitness levels were associated with the metabolic syndrome score. In general,
the metabolic syndrome score increased across groups. The normal-weight, high-fit group
had the lowest metabolic syndrome score and the overweight, unfit group had the highest
metabolic syndrome score. Children who were at risk for becoming overweight and had
high fitness had a lower metabolic syndrome score compared with those at-risk-foroverweight less-fit children. Their score was similar to that of the less-fit, normal-weight
children. To elaborate, a high fitness level resulted in a lower metabolic syndrome score
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in overweight children compared with overweight children with low fitness. They then
concluded that high fitness levels modified the impact that BMI had on the metabolic
syndrome score in children. Increasing a child's fitness level could be one method for
reducing the risk of obesity-related diseases or health problems. These findings, along
with the decrease of the metabolic syndrome score with obesity level as a result of being
aerobically fit, support the idea of being "fat but fit".
Whitaker’s study talked about being obese as a child leads to an increased risk of
being an obese adult, however, at the time the article was written, little was known about
how parental obesity affects the chances of a child becoming obese (1997). The aim of
this study was to explore obesity risk in young adulthood associated with both childhood
obesity and obesity in one or both parents. This was a retrospective cohort study, where
they used height and weight measurements from the outpatient medical records of a
cohort of young adults and their parents were part of a health organization in Washington
State. They identified 1333 members born between 1965 and 1970 to follow who had at
least one outpatient visit each after the age of 21 years. The majority of subjects had
come to the organization for most of their lives for routine care and check-ups. Of the
subjects, 854 met inclusion criteria for the study that included: at least one weight
measurement at the age of 21 or older, at least one height measurement at 18 years or
older for men and 16 years for women, no chronic disease or condition that could affect
weight, and birth at a gestational age of 9 months or more. The parents of all 854
subjects’ records were at the health center. The study defined childhood obesity
according adiposity indexes by height and weight (BMI). They used intervals of their
ages while growing up to create average BMIs. They followed a similar procedure for
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calculating the BMI of the parents. The authors found that at every age interval, both
obese and non obese children were at greater risk for becoming obese adults if at least
one parent was obese. The effect or parental obesity was most pronounced among obese
or and non obese children under 10 years of age. They found an even stronger likelihood
of adult onset of obesity if both parents were obese.
This is another interesting study in that it looks at the genetic link of becoming
obese. It demonstrates a clear relationship between having an obese parent or obese
parents and one’s risk for becoming an obese adult. Although it does not look at any
reasons or links between this relationship, it does garner further research because it
ultimately asks the question of “why/how does it increase one’s risk?” This question
could possibly be answered by looking at some biomarkers of obesity.
Dubose conducted a study dealing with aerobic fitness and metabolic syndrome
in normal weight, at risk-for-overweight, and overweight children (2007). There is excess
body weight in the youth population and it is positively correlated to metabolic
syndrome. Numerous studies are mentioned to demonstrate this theory. In both children
and adults, high fitness levels show better metabolic syndrome profiles across the board,
even in overweight or obese individuals. Studies have also demonstrated that youth who
are fit at an early age, tend to stay more fit throughout their lifetime. In addition to this
idea, studies have shown that better fitness levels lead to decreased risk of chronic
diseases. The purpose of Dubose’s study was to examine independent and combined
influences of BMI and aerobic fitness levels on metabolic syndrome in children. They
investigated whether metabolic syndrome score varied among normal weight, at-risk-foroverweight, and overweight children by aerobic fitness level. The authors hypothesized
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that aerobic fitness would attenuate the metabolic syndrome score within BMI categories.
The subjects in the study were part of a three year physical activity intervention called
Physical Activity Across the Curriculum. They also included a subsample of kids from 22
other elementary schools. The child had to be free of insulin-dependent diabetes,
cardiovascular disease, or any other disease impairing their ability to participate in
physical activity. There were 449 kids initially entered in the study, although only 375
ended up being included due to other confounding factors or incomplete tests. There were
equal numbers of boys and girls, and 27% of the sample was a race other than nonHispanic white. Baseline testing included: height, weight, circumference measures,
skinfold measures, resting blood pressure, fasting blood draw, aerobic fitness and
academic achievement tests, and physical activity and nutrition surveys. The main
measures of interest were height, weight, waste circumference, blood pressure, blood
chemistry, and aerobic fitness. The authors used a physical working capacity 170 cycle
ergometer test to assess aerobic fitness. They basically completed a serious of stages until
their heart rate was greater than 85% of their heart rate reserve or until they could not
longer hold a cadence of 60bpm. They basically created a metabolic score for children,
deriving it by standardizing the individual metabolic syndrome variables and then
regressed them by age, gender, and race. The standardized remaining numbers (z-scores)
were summed to create a continuous metabolic syndrome score. The variables chosen
were waist circumference, mean arterial pressure, HOMA, HDL, and triglyceride levels.
HDL was multiplied by -1 since it has the reverse affect on metabolic syndrome.
Statistical analyses used throughout the testing were independent t-tests, Pearson’s
correlations, analysis of covariance, and posthoc comparisons using tukey least-
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significant differences. Dubose’s study found that metabolic syndrome has obvious
relationships with both fatness and fitness. There were significant differences in the
metabolic syndrome score between BMI groups, with normal weight having the lowest
score and overweight having the highest score. They also found 35% of children in the
normal weight group possessed low fitness, whereas 30% of the at-risk-for-overweight
and overweight groups possessed high fitness. In general, the metabolic syndrome score
increased across groups, with the normal weight, high-fit group having the lowest
metabolic syndrome score and the overweight, unfit group possessing the highest score.
Also, the metabolic syndrome score was lower in children in the high-fitness group for all
three BMI classes when compared with their low fitness counterparts. To elaborate, a
high fitness level resulted in a lower metabolic syndrome score in overweight children
compared with overweight children with low fitness. The authors then concluded that
high fitness levels modified the impact that BMI had on the metabolic syndrome score in
children. Increasing a child's fitness level could be one method for reducing the risk of
obesity-related diseases or health problems. Considering that, one of the key points to be
made with these results is that they further support the idea of being “fat but fit” and
having a reduced risk of chronic disease compared to those who are not fat, but not fit
either.
The “fat but fit” idea is relevant to the present study because we do have a
population of subjects who could easily fall into this category. They were be clinically
obese, but will be otherwise healthy and capable of completing our tests and possibly
showing that they are fit. They will have no other cardiovascular risk factors which
means they are likely still pretty healthy. They may perform very well as our tests of
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physical fitness. Their risk for cardiovascular disease and cancer could then be less than a
seemingly healthy subject (who is thin) but does poorly on our fitness tests. Also, these
obese people may not have some of the mentioned biomarkers in the blood because they
are more fit, while a thin person who is at “risk” of becoming obese may have some of
these biomarkers show up in their blood. If we find some biomarkers linked to risk
factors in the blood of the healthy population, especially those who perform poorly, and
we do not find them in the blood of the obese population, specifically the ones who show
to have a higher level of fitness, it could support Blair’s idea of “fat but fit.”
Continuous vs. Intermittent Exercise
A study by Bloomer looked at biomarkers of oxidative stress in response to an
aerobic vs. anaerobic exercise protocol (2005). Although this is not exactly the same as
the present study, the aerobic protocol would be considered continuous while the
anaerobic protocol could be considered intermittent. The purpose of the study was to
compare oxidative modification of blood biomarkers in the 24 hours following aerobic
and anaerobic exercise using similar muscle groups. Ten cross-trained men between the
ages of 18 and 35 participated. They were all regularly participating in both anaerobic
and aerobic activities (no less than 3 days a week). To start, each subject completed a
VO2max test on the cycle ergometer. On separate occasions, they also performed a 1-RM
test on the bent knee squat exercise using free weights. They were given 6-8 attempts
with 3 minutes between attempts. This 1-RM was then used to calculate the weight
during the submaximal protocol. Within two weeks, subjects returned to the lab. They
took part in an overnight fast and asked not to exercise for the 48 hours prior to entering
the lab. Blood was then taken at rest before testing (Pre). In random order, subjects
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performed aerobic (continuous) and anaerobic (intermittent) exercise protocols in a cross
study design. The aerobic test consisted of subjects cycling warming up for 6 minutes,
with 2 minutes spend at 40, 50, and 60% of their VO2 max. The workload was then
increased to 70% of their VO2max and was adjusted every 5 minutes as necessary to stay
at 70% for entire 30 minute test period. A blood sample was taken immediately after the
30 minute session. For the anaerobic test, subjects started by warming up with 5 minutes
of stationary cycling and with 3 warm-up sets of the squat exercise for 5-6 reps each,
with 90-120 seconds between sets, at a weight equal to 40, 50, and 60% of their
previously recorded 1-RM. The weight was then increased to 70% of their 1-RM and it
was left at this weight for the entire 30 minute session. Each set was performed to the
point of momentary muscular failure (which was 5-12 reps) depending on the subject and
degree of fatigue as the protocol progressed. They rested for 90-120 seconds in between
sets. Their blood was also taken at the cessation of the 30 minute period. Blood was also
taken for both groups 1 hour, 6 hours, and 24 hours post exercise. The results of the study
suggest that 30 minutes of aerobic and anaerobic exercise performed can increase certain
biomarkers of oxidative stress in blood. However, they have different effects on these
oxidative stress biomarkers and result in a different magnitude of oxidation based on the
biomarker being looked it. They also found that protein oxidation was greater following
anaerobic exercise. This study demonstrates that it is likely differences will be noted in
the body’s physiological response to different modes of exercise. It can be expected that
if the physiological responses are different, there may also be changes in the blood profile
of these subjects.
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A study by Drust compared physiological responses in soccer-specific
intermittent and continuous exercise sessions (2005). They devised a protocol on a
treadmill that represented work rates similar to those performed on the soccer field. They
then compared the physiological responses between intermittent and continuous bouts of
exercise performed at the same average speed for 45 minutes. This study was a crossover design, so both groups came back another day and performed the other protocol.
They measured oxygen consumption, heart rate, rectal temperature, sweat production,
minute ventilation, and rating of perceived exertion. The authors found that there was no
significant differences in oxygen consumption, heart rate, rectal temperature, and sweat
production between the two types of exercise. However, average minute ventilation was
greater during intermittent exercise, as was rating of perceived exertion. Overall, this
study demonstrated that he demands of continuous and intermittent exercise are similar as
far as what they are asking the body to do. This study shows that it’s possible not to see
much difference in the blood biomarker profile between the two modes of exercise being
performed, especially since both protocols in the present study are to be considered
“maximal effort.”
Both of the previous studies are relevant to the present study in that it is looking at
differences in biomarkers before and after continuous vs. intermittent exercise, as well as
differences in these markers between the obese(but healthy) and non-obese. The previous
research suggests that in the same subjects, I may see some differences in biomarkers
depending on the mode of exercise. Although the biomarkers being investigated are not
the same ones looked at in the studies mentioned, it is still a fair assumption that they
may show differences as well depending on the type of training.
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CHAPTER 3
METHODOLOGY
Subjects
The desired subjects for this study consisted of two different groups of males
between the ages of 18 and 44, making them low risk according to ACSM guidelines. All
subjects filled out an informed consent document (See Appendix A). The first group
(N=9, ages 19-31) was comprised of healthy, non-obese males BMI (<30kg/m2) with
none of the following existing cardiovascular risk factors: high blood pressure, smoking,
dislipidemia, or diabetes. Exclusion criteria included being an athlete or completely
sedentary. The second group (N=9) consisted of males (ages 19-36) who are clinically
obese (BMI>30kg/m2), but otherwise healthy according to American College of Sports
Medicine Guidelines. (See Appendix B). This means that although they are obese, they
do not have high blood pressure, diabetes, dislipidemia, and are not a smoker. Additional
exclusion criteria for either group was that subjects could not have had a recent, major
change in body weight (lost or gained more than 20 pounds in the last 6 months). They
were also asked if they had none, one, or two parents that are overweight/obese (See
Appendix B). They also had a body fat percentage of greater than 25% to ensure the
excess weight is from adipose tissue (See Appendix C). Subjects were recruited from the
WKU student and faculty population, as well as the Bowling Green community.
Subject’s descriptive statistics can be found in Appendix D, table 3.1.
Prior to testing, the study was be approved by the Western Kentucky University
Human Studies Review Board (HS111-12), and all participants provided informed
consent.
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Protocol
Prior to day one of testing, each subject completed a risk stratification form to
determine if they met inclusion criteria (See Appendix A). Upon arrival to the lab, their
height and weight measurements were taken. Based on results, BMI was then calculated
immediately to ensure inclusion criteria were met. Body composition was then measured
using seven-site method with skinfold calipers (Lange Skinfold Caliper, BETA
technology, Santa Cruz, CA). Each measurement was taken twice per site, and provided
that the measurements were within 2 cm, a third measurement was not taken. The average
of the two measurements was calculated and the body fat percentage was determined
based on body density. Jackson and Pollock’s protocol was followed for the seven site
skinfold measurements and to determine body density (1978). The Siri equation was then
used to determine percent body fat based on body density (1961). The principal
investigator administered all skinfold measurements to prevent interpersonal variability.
On their first visit to the Exercise Physiology Lab, the subjects performed either a
maximal aerobic test to exhaustion (VO2 max test) or a series of Wingate Anaerobic
Cycling Tests. On the second visit, which was at least one week later, they returned and
performed whichever test they did not perform on the first visit. Half of the subjects
performed the VO2 test first and the other half performed the Wingate test first in this
counterbalanced study design. For the VO2 max test, a mouth piece attached by tubing to
the metabolic cart was placed in their mouth and a nose clip was used to keep all air from
entering or escaping through the nose. The air entering and exiting via the mouth was
analyzed by metabolic cart (True One 2400, Parvomedics True One Metabolic System,
Sandy, Utah), thus allowing oxygen, carbon dioxide, and RER levels to be carefully
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monitored throughout the test. Just prior to beginning the test, 600 microliters of blood
was obtained by finger pricking via lancets (Capijet Safety Lancet, Turumo Medical
Corporation, Somerset, New Jersey). Once a tiny incision was made by the lancet, blood
was then drawn into a test tube (Multivette 600, Sarstedt, Numbrecht, Germany).
Subjects were then put on the treadmill in order to start the Bruce protocol treadmill test
(Quintin TM55, Cardiac Science, Bothell, Washington). No warm-up was included
considering the first 3 minute stage of the protocol can be considered warm-up for all of
the participating subjects. The Bruce protocol is shown in detail in appendix E, figure
3.1. The test ended when the subject satisfied two of the following criteria: heart rate
within 10 beats of age-predicated max HR (220-age), RER >1.10, RPE≥20 (Borg scale),
or volitional fatigue. At any point, the test was ended if the subject requested to stop or
decided to stop and straddle the treadmill. The highest VO2 level recorded during the test
was considered their VO2 max. At the cessation of the max test, subjects were asked to
be seated and 600 microliters of blood was once again obtained. Blood was taken a final
time one hour after the exercise bout had ended.
For the Wingate Anaerobic test, the subjects followed the same protocol before
and after the exercise bout. Once blood was drawn, the Monark leg ergometer (Monark
828E cycle ergometer, Monark Exercise-AB, VANSBRO, Sweden) was adjusted for the
individual. They were encouraged to have a slight bend in the knee when sitting on the
bike with their foot in the stirrup at its lowest position. The standard Wingate protocol
was followed for each bout. They were asked to cycle as fast as possible for
approximately five seconds. Once they started pedaling at a maximal rate, the weight
(which was 7.5% of their body weight in kg), was placed on the flywheel. Once the
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weight was added, the time was started. The subjects were then asked to continue to
pedal as fast as they could for a 30 second time period. Every five seconds their RPM’s
were recorded. At the end of the 30 seconds, they were notified, and then allotted a twominute rest period in which they could sit, walk around, or continue to pedal slowly.
After two minutes, the 30 second test was repeated. After the second thirty second test,
they were given another two minute rest period. They were then asked to do a third, 30
second cycle test (Appendix F, figure 3.2). Immediately after the third test and one hour
after the completion of the test, 600 mircoliters of blood will be taken.
After each blood sample was obtained, it was centrifuged for 5 minutes (Myfuge,
Benchmark Scientific Inc, Edison, New Jersey). Plasma was then removed via pipettes,
placed in labeled test tubes, and stored in the freezer (Ultra Low Freezer, So-Low,
Cincinnati, Ohio) for later use.
The blood work was done according to specific protocols that accompanied each
of the kits. The following are the steps required for each kit.
CRP Assay Method
All reagents were removed from the refrigerator and allowed to reach room
temperature. Each lyophilized standard was reconstituted with 1.0 ml of deionized water,
mixed gently, and allowed to stand for 20 minutes. Each sample was diluted 100 fold by
adding 1 µl of plasma to 100 µl CRP dilutent. Then, 10 µl of CRP standards and samples
were added into appropriate wells, all of which were done in duplicate. Next, 100 µl of
CRP enzyme conjugate reagent was added to each well. The plate was then mixed gently
for 30 seconds and incubated at room temperature for 45 minutes. The incubated mixture
was then removed by being flicked over a waste container. It was then rinsed with
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deionoized water and flick into the waste container five times. The plate was then struck
sharply onto clean, dry, paper towels to remove all residual water droplets. At this point,
100 µl of TMB solution was added into each well, mixed gently for five seconds, and
incubated at room temperature for 20 minutes. At the end of the 20 minutes, the reaction
was stopped by adding 100 µl of stop solution to each well. The wells were mixed gently
for 30 seconds and once they changed from blue to yellow, absorbance was read with a
microtiter well reader (ELx800, Biotek Instruments, Vienna, VA) at 450nm within 15
minutes. Once read, a standard curve was created and the amounts of CRP in each sample
were calculated.
Leptin Assay Method
In preparation, the 5x assay wash buffer was diluted to 1x by adding 40 mL of the
5x assay wash buffer to 160mL of deionized water. The biotin-labeled mouse anti-human
leptin antibody was diluted 400x by adding 10mL of 1x dilutent buffer and the
streptavidin-HRP was diluted 200x by adding 10mL of 1x dilutent buffer before use. For
each sample, 90 µl of assay wash buffer was added to 10 µl of subject’s plasma.
Once prepared correctly, 100 µl of each standard and sample was added to the
appropriate wells, all of which were ran in duplicate. They were then allowed to incubate
for 1 hour at room temperature with gentle shaking (Vortex Genie Model G-560,
Scientific Industries Inc, Bohemia, NY). Each well was then aspirated and washed by
adding 200 µl of 1X assay wash buffer. This process was repeated for a total of three
washes. The complete removal of liquid was done by inverting the plate against, dry
paper towels. Then, 100 µl of diluted biotin-labeled mouse leptin antibody was added to
each well and the plate was incubated at room temperature for 1 hour. Each well was then
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aspirated and washed by adding 200 µl of 1X assay wash buffer. This process was
repeated for a total of three washes. The complete removal of liquid was done by
inverting the plate against, dry paper towels. Next, 100 µl of diluted streptavidin-HRP
conjugate was added to each well and incubated at room temperature for 45 minutes. The
aspiration/wash procedure was then performed for a third time. At this point, 100 µl of
substrate was added to each well and incubated for 10 minutes. Then, 50 µl of stop
solution was added to the wells, turning the color of them from blue to yellow. The
optical density was then determined by reading them on a microplate reader (ELx800,
Biotek Instruments, Vienna, VA) at 450nm within 30 minutes.
Statistical Analysis
Descriptive data for anthropometric and physiological variables were calculated
as mean + standard deviation (SD). All analyses were performed using the Statistical
Package for the Social Sciences (SPSS, version 18.0, Chicago, Ill., USA). Statistical
significance was set at an alpha level of p< 0.05 for all analyses.
An analysis of variance (ANOVA) with repeated measures was used to determine
differences between the resting serum levels of each biomarker and the serum
measurements immediately after and an hour after exercise. The repeated measures
analysis compared the resting, immediate-post, and 1 hour post measurements of each
biomarker. Post hoc analysis for multiple comparisons were analyzed using post hoc
procedure. The amounts of leptin and CRP in the blood pre-testing, post-testing, and
one hour post testing for each day of testing was analyzed with a 2x3 (group X time)
ANOVA with repeated measures on the last factor (time). This also examined effects
between groups (overweight vs. healthy). This was performed for both leptin and CRP.
Due to high variability and spread of the numbers, the obese group’s mean CRP and
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leptin levels at baseline were compared to each individual healthy subject’s CRP and
leptin levels post and 1-hour post exercise by using a one sample t-test (p<.05). This
addressed the question of “Are there healthy subjects who could be at a higher risk for
becoming overweight based on their post-exercises responses to these obesity-related
biomarkers?” This was done for both the wingate (intermittent) and VO2 max tests
(continuous) in order to answer the primary research question. Also, Pearson Product
Correlation Coefficients were used to determine if there was a correlation between
baseline levels of CRP (PRE) and measurements of body fat for both groups.
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CHAPTER 4
RESULTS
CRP
Using Pearson Product Correlation Coefficients, there was a significant positive
correlation between baseline levels of CRP (PRE) and measurements of body fat for both
groups. On the VO2 max test day, body mass index (r=.563, p=.018), body fat percentage
(r=.567, p=.018), and body weight (r=.533, p=.027) were all correlated to resting levels
of CRP. Refer to Appendix G-Figure 4.1, Appendix H- Figure 4.2, and Appendix IFigure 4.3, respectively. On the Wingate testing day, there was also a significant
correlation between baseline measurements of CRP and body mass index (r=.557,
p=.022), body fat percentage (r=.584, p=.014), and body weight (r=.593, p=.012). Refer
to Appendix J-Figure 4.4, Appendix K-Figure 4.5, and Appendix L-Figure 4.6,
respectively.
On the VO2 max testing day, the healthy group’s baseline mean CRP levels were
.49±.27 mg/dl. Immediately following the test, they decreased to .45±.25mg/dl, and
increased to higher than baseline at .52±.42 mg/dl one-hour following the end of the max
test. In the obese group, the mean CRP levels started at .94±.54mg/dl, increased to
1.18±.72mg/dl immediately after the VO2 max test, and decreased to near baseline at
.97±.60mg/dl 1 hour following the end of the exercise bout. A mixed analysis of variance
(group X time) was performed with repeated measures on the second factor (time), and
no significance was noted for main effect or interaction F(2,30=.987). However, in
response the first hypothesis, a paired sample t-test was performed, revealing a significant
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difference between the healthy and obese group’s baseline levels (PRE) of CRP. See
Appendix S, Table 4.1 and Figure Appendix U, Figure 4.13.
For the repeated Wingate trial, the healthy group’s baseline mean CRP levels
were .52±.26 mg/dl. Immediately following the test, they increased to.57±.48mg/dl, and
an hour post they decreased to below baseline at .48±.22 mg/dl. In the obese group, the
mean CRP levels started at .91±.44mg/dl, dropped slightly to .83±.36mg/dl immediately
after the VO2 max test, and returned to baseline at .90±.49mg/dl 1 hour following the end
of the exercise session. A mixed analysis of variance (group X time) was performed with
repeated measures on the second factor (time), and no significance was noted for main
effect or interaction F(2,30=.057). Differences are evident, however, none of them are
considered statistically significant. See Appendix T, Table 4.2 and Appendix U, Figure
4.13.
Based on these data, it can also be noted that the baseline CRP levels are
significantly higher in the obese group on the VO2 testing day, and although not
demonstrated statistically, there is a distinction between the baseline measurements
between groups on the Wingate day as well.
Due to large variability, each healthy subject was individually investigated to
determine those who may be at risk for becoming obese. See Appendix V Figure 4.14
and Appendix W, Figure 4.15. This addresses the issue of trying to identify if there are
any healthy subjects who could be at a higher risk for becoming overweight based on
their post-exercises responses to this inflammatory marker. This was done for both the
Wingate (intermittent) and VO2 max test (continuous).

41

Leptin
Using Pearson Product Correlation Coefficients, there was a significant
correlation between baseline levels of leptin and measures of body fatness for both
groups. Before the VO2 max test, there was a significant correlation between serum
Leptin levels and body mass index (r=.632, p=.005), as well as body weight (r=.575,
p=.013). Refer to Appendix M, figure 4.7 and Appendix O, figure 4.9. There was not a
significant correlation between leptin level and body fat percentage (r=.459, p=.055).
Refer to Appendix N, figure 4.8. On the Wingate testing day, there was also a significant
correlation between baseline measurements of Leptin and body mass index (r=.624,
p=.006), body fat percentage (r=.484, p=.042), and body weight (r=.579, p=.012). Refer
to Appendix P-Figure 4.10, Appendix Q-Figure 4.11, and Appendix R-Figure 4.12,
respectively.
For the VO2 max test, the healthy group’s baseline mean leptin level was
5.97±5.88 ng/ml. Immediately following the test, they increased to 6.64±6.51ng/ml, and
an hour post they slightly decreased to 6.29±5.45 ng/ml. In the obese group, the mean
leptin levels started at 19.80±14.74ng/ml, increased to 23.66±16.67 ng/ml immediately
after the VO2 max test, and returned to baseline at 19.75±15.79ng/dl 1 hour following the
end of the exercise bout. See Appendix X, Table 4.3 and Appendix Z, Figure 4.16. A
mixed analysis of variance (group X time) with repeated measures on the second factor
(time) was used and a main effect was found F(2,32 = 3.903, p=.021). Post-hoc analysis
confirmed significant differences between healthy and obese groups between pre, post,
and 1-hour post measurements. No interaction was found between variables was found.
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For the repeated Wingate trial, the healthy group’s baseline mean serum leptin
levels were 5.39±4.24 ng/ml. Immediately following the test, they increased to
6.98±5.72ng/ml, and an hour post they decreased to near baseline levels at
5.59±3.99ng/ml one-hour following the end of the three cycle tests. In the obese group,
the mean leptin levels started at 18.68±13.29ng/dl, climbed slightly to 20.30±12.13ng/ml
immediately after the Wingate tests, and returned to baseline at 18.96±10.31ng/ml 1 hour
following the end of the exercise session. Changes are evident, however, none of them
are considered statistically significant. A mixed analysis of variance (group X time) with
repeated measures on the second factor (time), and no significance was noted for main
effect or interaction F(2,32=.800). See Appendix Y, Table 4.4 and Appendix Z, table
4.16.
Due to large variability, each healthy subject was individually investigated to
determine those who may be at risk for becoming obese. See Appendix AA, Figure 4.17
and Appendix BB, Figure 4.18. This addresses the issue of trying to identify if there are
any healthy subjects who could be at a higher risk for becoming overweight based on
their post-exercises responses to this inflammatory marker. This was done for both the
Wingate (intermittent) and VO2 max test (continuous).
VO2 vs. Wingate
In comparing the VO2 (continuous) and the Wingate (intermittent) protocols, there
was no significant main effect F(2,26=.005) or interaction F(2,26=.433) for CRP levels in
the healthy group. For CRP levels in the obese group, a significant interaction
F(2,32=3.41) was demonstrated, while there was not a significant main effect
F(2,32=.942) shown. Post hoc analysis indicated a significant difference between CRP
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post and CRP 1-hour post exercise in the obese group on the VO2 testing day (p=.037).
Appendix S, Table 4.1 and Figure Appendix U, Figure 4.13.
In comparing the VO2 (continuous) and the Wingate (intermittent) protocols, there
was no significant main effect F(2,32=1.149) or interaction F(2,32=.261) for Leptin
levels in the healthy group. Likewise, no significant main effect F(2,32= 2.30) or
interaction F(2,32=.467) was reported for the obese group.
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CHAPTER 5
DISCUSSION
The present study was designed to examine baseline, post, and 1 hour post
measurements of CRP and leptin in the blood of those who were healthy and those who
were obese but otherwise healthy. The primary purpose was to compare the biomarkers in
a healthy person’s blood when recovering from exercise to an obese person’s biomarkers
at rest. It was hypothesized that obese subjects would have higher baseline measures in
both markers, and that the healthy group may show some similarities to the obese group’s
elevated resting numbers in the post-exercise and 1-hour post exercise measurements.
Overall findings suggest that obese subjects generally have higher levels of CRP and
leptin before, after, and 1 hour after intense exercise. However, when examining
individuals, some healthy subjects demonstrated spikes in these markers, suggesting that
they could be at risk for obesity and its related disease states. Also, the Wingate and VO2
tests demonstrated differing effects on the two groups, although notable, none of these
changes were too dramatic with only one decrease considered statistically significant.
On both of the testing days, CRP levels differed between the healthy and obese
groups at baseline. On the VO2 testing day, this difference was considered statistically
significant. This confirms the initial hypothesis that resting levels of CRP would be
higher in those who are considered clinically obese, based on the fact that this biomarker
has been tightly linked to chronic inflammation and obesity. This finding is consistent
with the findings of Park (2005) who demonstrated that CRP is significantly correlated
with BMI. In the present study, BMI was significantly higher in the obese group, with all
subjects in that group having a BMI over 30kg/m2. Baseline CRP levels were also
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significantly higher in this group, thus, confirming Park’s findings. Our results are also in
line with those of Nguyen, who noted that as weight class went up, so did CRP levels
(2009). Overall, the present study’s baseline differences are consistently in line with
previous literature that connects obesity and CRP (Lieb 2008, Visser 1999, Ford 1999).
In addition to CRP’s links to obesity, it becomes indirectly linked to other disease states
and chronic conditions associated with obesity. These include cardiovascular disease,
diabetes, hypertension, and dislipidemia. CRP has also recently shown great clinical
utility in assessing progress of chronic inflammatory conditions (Mussad, 2007).
However, the key problem in using it to assess cardiovascular disease and other
conditions is that it is not specific to obesity, which produces the need for studying
biomarkers linked more exclusively to obesity. The use of these biomarkers could
eventually be very useful in predicting likelihood of becoming obese or suffering from
any of obesity’s subsequent disease states, especially in certain subpopulations.
When examining the results of the CRP tests, it is notable that some differences
appear to exist between the two groups. Although there is no significant main effect or
interaction effect, the results still show that regardless of the time blood was drawn, CRP
levels were higher in those who were obese. A statistically significant difference was
demonstrated on the Wingate testing day when comparing the PRE levels in both groups,
thus, confirming the fact that CRP levels vary according to body weight, with the obese
group having noticeably higher levels throughout testing. It is noteworthy that CRP levels
above 1.0 mg/dl is considered “elevated” in a clinical setting. Therefore, both of the mean
resting measurements for the obese group were very near to this level. Additionally,
many obese subjects had levels well over 1.0 mg/dl. It is interesting to note that with the
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VO2 testing, the obese groups numbers increased, then back near baseline after 1 hour.
This fall back to baseline from post to 1 hour post was statistically significant, showing
that exercise had noticeable effects on CRP levels in these subjects. During the Wingate
testing, they increased post-exercise, and then returned to baseline 1 hour later. Although
most of these climbs and drops in CRP levels were not statistically significant, it is
interesting to note that the healthy population’s responses were the exact opposite. The
amount of serum CRP increased following the Wingate, then decreased to near baseline
an hour post. With the VO2 test, their serum CRP levels fell post-exercise and returned to
near baseline levels 1 hour later. It can then be noted that the only slight changes were in
the immediate post exercise measurement. The pre and 1-hour post measurements were
very similar to each other in all cases.
When comparing the two protocols, the Wingate appeared to have a more
aggressive effect on the healthy group’s CRP levels, and the VO2 appeared to have a
more aggressive effect on the obese group’s. The small spikes or drops in CRP levels
immediately after exercise may demonstrate differences in the effect that continuous and
intermittent exercise has on different populations. Since CRP is an inflammatory marker,
it is possible it rises as muscles become fatigued, thus, damaged and possibly inflamed.
This could help explain these findings in that the obese group seemed to induce more
damage during the Wingate trials. This is logical in that they were actually more able to
“slack off” in this stage of the experiment. There was no cadence or set speed they had to
reach, and many of the obese subjects nearly came to a dead stop when pedaling during
the test. This could be attributed to the higher amount of weight on the fly wheel (since it
is a percentage of their body weight), or it also could be that they were able to not try as
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hard on this test. On the treadmill test, however, the speed and grade kept changing and
they had no choice but to maintain their effort until they were at exhaustion or a max.
Based strictly on observation, it can be noted that the effort produced for the obese group
was higher on the VO2 test than the Wingate. In the healthy group, the changes from pre,
post, and 1 hr post were slightly smaller, and the response was the opposite. Some of
these subjects were recreational runners and worked out on a more regular basis.
Therefore, the running (treadmill test) may have been a more familiar and comfortable
modality for them, thus, possibly inducing less inflammation and CRP. For future study,
measuring RPE could be beneficial in assessing this issue. Another theory for this could
be the way that the groups responded to continuous or intermittent activities are different.
A more continuous activity may be seemingly easier for the healthy group, who based on
having higher VO2 maxes, should have enhanced cardiorespiratory endurance. The
intermittent activity however, which uses more of an anaerobic energy system, may have
caused them more stress. In the obese group, the continuous activity without breaks was
perhaps more difficult for them, thus, causing the spike of CRP after exercise. Based on
previous literature by Bloomer, both intermittent and continuous activities can increase
certain biomarkers of oxidative stress in blood (2005). This is consistent with our
findings in that both types of exercise demonstrated some changes in these markers.
However, it appears that it varies from person to person, likely depending on their
abilities, training programs, and exercise modalities.
The general trend was for the healthy groups CRP and Leptin levels to be below
obese groups in the pre, post, and 1 hour post measurements. The healthy subjects that
showed increases in either biomarker after exercise are the ones of most interest to this
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particular study. The purpose of the present study was to assess those individuals who
may be “at risk” based on their responses to exercise. The subjects’ data were analyzed
individually to see if any had spikes of CRP after the exercise bouts. Another
consideration when examining this portion of the data is parental obesity. Subjects were
asked to report if they had at least one overweight or obese parent, and of the 9 healthy
subjects, three of them (subjects 1, 4, and 7) had 1 obese parent. For the VO2 test,
subjects 4, 5, 6, and 7 all had noticeably increased levels of CRP after the exercise bout
(either in post or 1-hour post) when compared to baseline. Of the four subjects that had
spikes post or 1-hour post exercise in this case (4, 5, 6, and 7), 2 of them had at least 1
obese parent (4 and 7). This is relevant in that research has shown obesity has a genetic
component. Leib found that parental obesity increases the risk for becoming obese or
having obesity related conditions, even in the absence of obesity (2008). He also found
that higher CRP levels were observed in offspring that were not obese, but had obese
parents. Subjects 4 and 7 had heightened CRP levels post-exercise, and based on their
parents, are a higher risk for becoming overweight. When analyzing the Wingate test
data, subjects 1, 2, 5, and 8 produced higher levels of CRP after exercise. Subject 1 is the
third subject who reported having at least one overweight parent, which is again
interesting in that parental obesity has a tendency to be passed on to their offspring.
Much like CRP, serum baseline levels of leptin were also significantly higher in
the obese group on one of the testing days. This is consistent with the initial hypothesis,
as well as in line with previous literature. Soderberg and colleagues concluded that high
levels of leptin were positively associated with BMI (1999). Shutte drew similar
conclusions finding leptin levels were clearly elevated in subjects who were overweight
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or obese (2005). Muassad pointed out that leptin can also increase cardiovascular disease
risk by increasing production of inflammatory biomarkers, such as CRP (2007). The fact
that both of these biomarkers increased according to BMI class and body fat percentage
falls directly in line with previous literature.
When analyzing leptin levels, both groups experienced a very slight (not
significant) increase post-exercise, and a return to baseline one hour later. There was no
difference between groups in the leptin response to exercise modality. Much like CRP,
leptin levels were examined on an individual basis to determine those who may be at risk
for obesity and its subsequent disease states. In examining the VO2 test, subjects 5, 6, and
9 had elevated leptin levels post exercise. It can be noted here that subject six also saw a
spike in CRP after the VO2 test. This not only makes them of greater interest based on
their risk for obesity, but it also helps to possibly rule out the fact that CRP was raised for
additional reasons than acute inflammation. When examining the Wingate, subjects 4, 5,
7, 9 had elevated levels of leptin after exercise (either post, 1 hr post, or both). Four and
seven were two of the subjects noted in looking at CRP. They both had at least one
overweight/obese parent. Subjects 5 and 9 had elevated leptin responses with both modes
of exercise, thus pointing to possibly being at an increased risk for obesity and its disease
states. At closer examination, subject 5 had elevated responses post-exercise in all four
measurements (crp-vo2, crp-w, leptin-vo2, leptin-w). Subject 9 (who is actually number 8
in the CRP results due to the removal of an outlier), had elevated responses in three of the
four. Those are the two subjects, based on the assumptions made in the present study,
could be at the highest risk for becoming overweight based on their biomarkers. Along
with them, 1, 2, 4 and 7 garner further investigation.
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With several healthy individuals standing out as possibly being at increased risk
for becoming overweight, it leads one to wonder if any of these healthy subjects are
actually have greater risk than some currently obese subjects for carrying excess weight
later in life and/or developing obesity related disease states such as cardiovascular
disease, hypertension, diabetes, dislipidemia, etc. Could it be possible that some of the
obese subjects may actually be “healthier” in a long-term sense? Although the average
VO2 maxes were higher in the healthy group, is it possible that several obese subjects
were actually more fit than several healthy subjects? A possible example is subject 3 in
the obese group. He possessed no risk factors for cardiovascular disease except for that
he had a BMI over 30, similarly to all subjects in this group. However, his VO2 max was
58.2 ml/kg/min, which was well over the mean VO2 max for the healthy group (54.66
ml/kg/min). In fact, the highest VO2 max of all 18 subjects was 60.2 ml/kg/min,
therefore, he was not far from having the highest cardiorespiratory endurance of even the
healthy group. This is relevant to the “fat but fit” notion previously mentioned in that
although he was bigger than many of the healthy subjects, he was fitter (Blair 1989).
Additionally, he did not see post-exercise spikes in these biomarkers, so perhaps he is
actually at less risk than some of his healthy counterparts for developing obesity related
conditions later in life. The “fat but fit” notion is connected with a great deal of literature
examining the genetic component of obesity. A study by Whitaker explores the genetic
link of becoming obese, finding a very clear connection (1997). It demonstrates a
relationship between having an obese parent or obese parents and one’s risk for becoming
an obese adult. Although it does not look at any reasons or links between this
relationship, it does garner further research because it ultimately asks the question of
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“why/how does it increase one’s risk?” This question could at some point, with more
research, could possibly be answered by looking at leptin, CRP, and other biomarkers of
obesity.
When comparing the two protocols, the Wingate appeared to have a more
aggressive effect on the healthy group, and the opposite was true for the obese group.
Based on investigating individual subjects, many had different responses to different
modes of exercise. This is likely based on individual’s ability as well as previous training
status. Some subjects may have been more accustomed and/or more comfortable with
particular modes of exercise. Based on previous literature by Drust, continuous and
intermittent activities often produce similar physiological responses (2005). Drust’s study
shows that it is possible not to see much difference in the blood biomarker profile
between the two modes of exercise being performed. This is especially relevant to the
present study since both protocols in the present study are to be considered “maximal
effort.” Our findings are consistent with this idea in that the only significant change in
either biomarker noted was for CRP between the post and 1 hour post for the VO2 max
test. Thus, showing that the other responses were statistically insignificant and, therefore,
similar to each other.
In the present study, numerous limitations were noted. The first limitation is that
much of the present study was based upon assumption. The idea that the obese subjects
are in a “chronic disease state” and the healthy subjects post-exercise are in a “temporary
disease state” is based on quality logic; however, there is still a great deal of assumption
going into the backbone theme of this study. Another major limitation was that before
most serum leptin or CRP tests, individuals are required to do a 12 hour fast the night
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prior. In the current study, they were not asked to fast. However, subjects were asked not
to eat 4 hours before coming into the lab, thus it was considered, but we did not directly
control for it. A longer fast could not really be a requirement considering they were
doing maximal effort protocols on both days they came in; therefore, some fuel was
necessary in order to perform. Technically, the present study did not have a “fasting”
baseline blood sample. However, the post and 1 hour post measurements can be
considered more valid in the sense that much like fasting, the exercise protocol performed
was an activity resulting in a calorie deficit. Another notable limitation we did not control
for exercise between sessions. Subjects were asked not to exercise 48 hours upon arrival,
but the other 5 days in between the sessions were not controlled. This could be limiting in
that some subjects possibly had lingering effects from a workout 3 days before they came
in, however, this is not very likely considering most soreness, etc. is alleviated after 48
hours. Also, individuals’ motivation and effort can not be directly controlled.
Additionally, time constraints were another major limitation. Based on a power analysis
performed, 15 subjects per group would have been ideal. However, having only one
semester to complete this project, only 9 per group were obtained. Recruiting willing
obese subjects also was difficult. If the number of participants had been higher, thus
providing appropriate statistical power, this may have yielded more significant findings.
An additional and important limitation is in examining CRP as a biomarker of obesity.
CRP is an inflammatory biomarker linked tightly with chronic inflammation and obesity.
However, it could be elevated in subjects for other, more acute reasons. This makes it
difficult to “trust” any CRP-related findings in that they could be attributed to other
causes or conditions. Musaad explains that CRP had recently shown great clinical utility
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in diagnosing inflammatory conditions (2007). However, the fact that it is not specific to
obesity alone makes it difficult to study.
Due to the fact that the present study is extremely novel, and nothing similar has
been done before, the need for future study is not only vital, but multidirectional. First, if
the study is repeated, it is recommended to measure RPE for both exercise tests. This
would give a better idea of the effort being put forth in both activity sessions. Also,
examining a 24-hour post measurement would be interesting to see how long some of the
biomarkers stayed elevated. For some subjects, they had already come back to baseline 1hour post. However, some spiked an hour after, so specifically for them, seeing what
happened 24 hours later would possibly help make some better observations. Perhaps
some of these healthy subjects saw these “spikes” 24 hours later when the delayed onset
muscle soreness was in full effect. This could demonstrate that perhaps the CRP was
elevated for other reasons, such as exercise-related inflammatory causes. Another route
this research could take is analyzing the same subjects longitudinally. Take the present
study for example, and have these same subjects are tested every 6 months for 20 years.
During the visit, they would have weight, body mass index, body composition, and blood
pressure measurements taken. Perhaps some of the men we identified as being “at risk”
would have gained weight and would now be considered overweight or obese. It is
possible that some of them may have developed high blood pressure or other obesity
related conditions. If this could be noted, then the results of the present study could be
somewhat substantiated in that our “predictions” seemed to have some authority. A final
and important consideration for future research rests in selection of biomarkers.
Exploring biomarkers more specific to obesity may be better than ones like CRP that
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have other explanations behind their appearance in blood. Musaad reports that there is
clinical need for biomarkers that are specific to obesity and that can predict risk for
cardiovascular disease (2007). Future study should seek these biomarkers. However, if
ones such as CRP are evaluated, the additional factors that affect its presence in the blood
should be controlled.
Overall, a great deal was investigated and analyzed over the course of the present
study. A major baseline finding is that the obese group had higher levels of CRP and
leptin in resting conditions. After the VO2 test, the obese group’s CRP levels increased,
while the healthy group’s decreased, and both groups returned to baseline at 1 hour post.
After the Wingate testing, the two groups basically switched their responses. In looking
at leptin on both testing days, both groups saw a slight increase immediately after
exercise and numbers returned to baseline 1-hour post. However, significant differences
between the groups were noted on all measurements on the VO2 testing day. In looking at
subjects on a more individual basis, subjects 5 and 9 stood out as possible “at-risk”
participants. Subjects 1, 4, and 7 also had notable responses, as well as being the
offspring of parental obesity, thus, putting them in position to be studied more
extensively as well. These results, however interesting, need further investigation and
validation with future study. The novel basis of the present study adds to its unique
nature, but also calls for more research on this hot topic in today’s society. Obesity has
been recently called an “epidemic,” and this study is one tiny step in the direction of
finding solutions.
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INFORMED CONSENT DOCUMENT
Project Title: INVESTIGATION OF C-REACTIVE PROTEIN AND LEPTIN AS BIOMARKERS OF
OBESITY WITH POTENTIAL CLINICAL UTILITY
Investigator: Rachel Friedman, Department of Kinesiology, Recreation, and Sport, (618)604-2712.
You are being asked to participate in a project conducted through Western Kentucky University. The
University requires that you give your signed agreement to participate in this project.
The investigator will explain to you in detail the purpose of the project, the procedures to be used, and the
potential benefits and possible risks of participation. You may ask him/her any questions you have to help
you understand the project. A basic explanation of the project is written below. Please read this
explanation and discuss with the researcher any questions you may have.If you then decide to participate in
the project, please sign on the last page of this form in the presence of the person who explained the project
to you. You should be given a copy of this form to keep.
1.
Nature and Purpose of the Project: The main purpose of this project is to compare biomarkers
of those who are clinically obese (BMI ≥30kg/m2) to those who have a healthy (BMI<30). The four
biomarkers that will be studied are leptin, tumor necrosis factor-α, C-reactive protein, and interleukin-6. All
four of these can be found in the blood, and they are each associated with obesity and other disease states
related to obesity. The idea behind the study is to see if there are similarities in the obese group’s blood at
rest and the healthy group’s blood after the exercise bout, because in both situations the body is in a
“disease state” and/or is “stressed.” If there are similarities, it could be possible to do a simple finger prick
in place of an extensive diagnostic exam. The results could indicate a way to “predict” obesity and its
subsequent disease states.
2.
Explanation of Procedures: On your first visit to the Exercise Physiology Lab, you will perform
either a maximal treadmill test to exhaustion or a series of cycling tests. On the second visit, at least one
week later, you will come in and perform whichever test you did not perform on your first visit. For the
treadmill test, a mask will be placed over your nose and mouth so that expired air can be measured. Prior to
the start of the test, blood will be drawn by finger pricking. You will then be put on the treadmill (with the
mask still on your face) and given a three minute warm-up period at a comfortable speed. You will then
begin the Bruce protocol treadmill test (a standard test that slowly increases in speed and incline every
stage). The test will end when you satisfy two of the criteria indicating you have reached a maximal effort.
At any point, the test will also end if you request to stop. As soon as the test is complete, blood will again
be taken via the needle prick method. At the end of the recovery period (1-hour), blood will once again be
drawn via the finger prick method.
For the Wingate Anaerobic test, they will follow the same protocol before and after the exercise
bout. You will then be asked to sit comfortably on the cycle. The standard Wingate protocol will then be
followed for each bout. You will be asked to cycle as fast as you can for a matter of seconds. Once you
start peddling at a maximal rate, the weight (which was 7.5% of your body weight in kg), will be placed on
the flywheel. Once the weight is added, the time will be started. You will be asked to continue to peddle as
fast as you can for a 30 second time period. At the end of the 30 seconds, you will be notified, and will then
be allotted a two-minute rest period in which you can sit, walk around, or continue to peddle slowly. After
two minutes, the 30 second test will be repeated. After the second thirty second test, you will be given
another two minute rest period. You will then be asked to do a third, 30 second cycle test. Immediately
after the test, blood will be drawn. It will be drawn a final time 1-hour after completed the Wingate cycle
tests.
3.
Discomfort and Risks: The main risks associated with this study are in performing the maximal
effort exercise. The treadmill test is an incremental run to exhaustion that maximally stresses the
cardiorespiratory system. The increased myocardial demand of maximal intensity exercise may precipitate
cardiovascular events in individuals with heart disease. However, the American College of Sports Medicine
has stated that the risk of death during or immediately after an exercise test is less than or equal to 0.01%,
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while the risk of an acute myocardial infarction is less than or equal to 0.04%. Data from these surveys
included a wide variety of healthy and diseased individuals. As you have been screened to be a healthy
“low risk” individual, the risks are estimated to be considerably lower. Another risk would be muscle
soreness from the intense efforts required for the exercises. A final risk would be slight soreness on the
finger from being pricked.
4.
Benefits: The direct benefit to you is the information you will receive regarding aerobic fitness
level. General benefits from the research are that the knowledge generated could become very useful in
assessing risk for obesity and other disease states, as well as diagnosing these conditions.
5.
Confidentiality: You will be assigned a numerically coded identification number. Your data will
be stored on computer disks, which will be locked in the primary investigators office (Smith Stadium
1039).
6.

Refusal/Withdrawal:

Refusal to participate in this study will have no effect on any future services you may be entitled to from
the University. Anyone who agrees to participate in this study is free to withdraw from the study at any
time with no penalty.
You understand also that it is not possible to identify all potential risks in an experimental procedure, and
you believe that reasonable safeguards have been taken to minimize both the known and potential but
unknown risks.
__________________________________________ _______________
Signature of Participant

Date

__________________________________________ _______________
Witness

Date
THE DATED APPROVAL ON THIS CONSENT FORM INDICATES THAT
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY
THE WESTERN KENTUCKY UNIVERSITY INSTITUTIONAL REVIEW BOARD
Paul Mooney, Human Protections Administrator
TELEPHONE: (270) 745-4652
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ACSM Initial Risk Stratification Questionnaire
Please provide accurate information for all requested items. Ask a staff member to assist you if
you need clarification of any item.
Name: ____________________________________________
Date of Birth: __________________
Write a Y for all statements that are true, write a N for all statements that are false, and write a U
for all statements that are unknown.
Cardiovascular Risk Factors
_____ You have a first-degree relative who had a heart attack or coronary revascularization or
sudden death before age 55 (father or brother) or age 65 (mother or sister).
_____ You smoke cigarettes or you quit smoking cigarettes within the last 6 months.
_____ Your systolic blood pressure is > 140 or your diastolic blood pressure is > 90 mmHg or
you take blood pressure medication.
_____ Your LDL-cholesterol is > 130 mg/dl (if LDL not known: your total cholesterol is > 200
mg/dl) or your HDL-cholesterol is < 40 mg/dl or you take lipid lowering medication.
_____ You are sedentary (i.e. you get less than 30 minutes/day of moderate intensity physical
activity on most days and you do not participate in a regular exercise program).
_____ Your HDL-cholesterol is > 60 mg/dl
Symptoms
_____ You experience pain or discomfort in the chest, neck, or arms.
_____ You experience shortness of breath at rest or with mild exertion.
_____ You experience dizziness or have had episodes of blackouts.
_____ You have swelling of the ankles
_____ You experience shortness of breath with change of posture or while sleeping
_____ You experience episodes of rapid heart beats or skipped heart beats.
_____ You experience pain or cramping sensations in your legs when walking.
_____ You experience fatigue or shortness of breath with unusual activities.
Medical History
List all other notable health problems, injuries, or conditions
You have or have had:
_____ Heart murmur _____ heart attack
_____ heart surgery _____ a lung disease
_____ a metabolic disease (diabetes, thyroid disorder, kidney or liver disease)
List names/doses/frequency of all medications taken (if not taking any medications, write
“NONE”)
ACSM initial risk stratification (circle classification):
LOW
MODERATE
HIGH
Have you lost or gained more than 20 pounds in the last 6 months? Y or N
Are you an “elite” level athlete? Y or N
How many (if any) of your biological parents are overweight/obese? 0 1
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Skinfold Test Evaluation
Athlete Name: _________________________________ Gender:_________ Age:_________
Sport:

_________________________________

Strength and Conditioning Coach: _______________________________

Skinfold Measurements
Trial
1

2

3

4

Average

Triceps

________

________

________

________

_______

Subscapular

________

________

________

________

_______

Chest

________

________

________

________

_______

Midaxillary

________

________

________

________

_______

Suprailiac

________

________

________

________

_______

Abdomen

________

________

________

________

_______

Thigh

________

________

________

________

_______

Skinfolds

Sum of Skinfolds:
Calculations: (Jackson-Pollock)
Body Density: __________________

Percent body fat: _________
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Table 3.1
Descriptive data (Means ±SD)
Descriptive

Healthy

Obese

Significance

Age(yrs)

21.6±3.9

24.8±5.4

p=.168

Height(m)

1.77±.07

1.78±.08

p=.852

Weight (kg)*

73.44±8.40

110.03±13.92

p=.000

BMI (kg/m2)*

23.31± 2.58

34.63±2.54

p=.000

Body Fat % *

13.18±4.34

28.96±2.03

p=.000

VO2

54.66±6.7

41.74±8.6

p=.003

max(ml/kg/min)*
*Denotes statistical significance between groups (p<0.05)
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Figure 3.1
Bruce Treadmill Protocol

Arnell, 2006.
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Figure 3.2
Repeated Wingate Anaerobic Protocol
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Figure 4.1
Correlation between BMI and resting CRP Levels on VO2 max testing day
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Figure 4.2
Correlation between body fat percentage and resting CRP levels on VO2 Max testing day
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Figure 4.3
Correlation between body weight and resting CRP levels on VO2 max testing day

74

Appendix J

75

Figure 4.4
Correlation between body mass index and resting CRP values on Wingate testing day
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Figure 4.5
Correlation between body fat percentage and resting CRP levels on Wingate testing day
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Figure 4.6
Correlation between body weight and resting CRP levels on Wingate testing day
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Figure 4.7
Correlation between body mass index and resting Leptin levels for VO2 Max testing day
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Figure 4.8
Correlation between body fat percentage and resting Leptin levels on VO2 Max testing
day
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Figure 4.9
Correlation between body weight and resting Leptin levels on VO2 Max testing day
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Figure 4.10
Correlation between body mass index and resting Leptin levels on Wingate testing day
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Figure 4.11
Correlation between body fat percentage and resting Leptin levels on Wingate testing day
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Figure 4.12
Correlation between body weight and resting Leptin levels on Wingate testing day
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Table 4.1
Mean CRP levels (mg/dl) for VO2 max testing

1-HOUR
PRE*
POST
POST
Healthy .49±.27 .45±.25
.52±.42
Obese .94±.54 1.18±.72 **.97±.60
Note: *indicates significant difference between healthy and overweight group at baseline
(p<0.05). ** Indicates a significant decrease in CRP levels from POST to 1-HOUR
POST.
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Table 4.2
Mean CRP levels (mg/dl) for series of Wingate cycle tests

1- HOUR
PRE
POST
POST
Healthy .52±.26 .57±.48
.48±.22
Obese
.91±.44 .83±.36
.90±.49
Note: Pre levels are not considered statistically significant from each other, however,
numbers are similar to those seen on VO2 testing day.
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Figure 4.13
Comparison of Healthy vs. Obese Mean CRP Levels Based on Exercise Mode
1.4

1.2

CRP levels (mg/dL)

1

0.8

Healthy VO2
"Healthy Wingate"

0.6

Obese VO2
Obese Wingate

0.4

0.2

0

Pre

Post

1 hour‐post

Note: CRP levels in both the healthy and obese groups pre, post, and 1 hour post for the
VO2max(continuous) test as well as Wingate test (intermittent). Indicates significant
drop in CRP levels from POST to 1-HOUR POST.
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Figure 4.14
Healthy Individual Subject’s Pre, Post, and 1-Hour Post CRP Levels for the VO2 Testing
Day
1.6
Pre

1.2

Post

CRP levels (mg/dL)

1.4

1‐hour post

1

0.8

0.6
0.4
0.2
0
1

2

3

4

Subject

5

6

7

8

Note: Comparisons here can be used to determine healthy individuals with a possibly
elevated risk for becoming obese. There are only 8 subjects because the 8th of 9 subjects
was removed as an outlier with clinically high (>4.0 mg/dl) levels of CRP. Line at .94
denotes mean CRP levels at rest for the obese group.
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Figure 4.15
Healthy Individual Subject’s Pre, Post, and 1-Hour post CRP Levels for the Wingate Test
Session
2
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CRP (mg/dL)
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1

0.8
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0.4
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1

2
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4
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8

Subject

Note: Comparisons here can be used to determine healthy individuals with a possibly
elevated risk for becoming obese. There are only 8 subjects because the 8th of 9 subjects
was removed as an outlier with clinically high (>4.0 mg/dl) levels of CRP. Line at .91
denotes mean CRP levels at rest for the obese group.
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Table 4.3
Mean Leptin levels (ng/ml) for VO2 max testing

1-HOUR
PRE*
POST*
POST*
Healthy
5.97±5.88
6.64±6.51
6.29±5.45
Obese 19.80±14.74 23.66±16.67 19.75±15.79

Note: * Indicates a significant difference between the healthy and obese groups at pre,
post, and 1-hour post measurements.
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Table 4.4
Mean Leptin levels (ng/ml) for Wingate Testing Day

1-HOUR
*PRE
POST
POST
Healthy
5.39±4.24
6.98±5.72
5.59±3.99
Obese 18.68±13.29 20.30±12.13 18.96±10.31

Note : *indicates significant difference between healthy and overweight group at
baseline (p<0.05).
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Figure 4.16
Leptin levels in both the healthy and obese groups pre, post, and 1 hour post for the
VO2max(continuous) test as well as Wingate test (intermittent)

25

Lep<n Levls (ng/ml)

20

15

Healthy VO2
Obese VO2
healthy wingate

10

Obese Wingate

5

0

Pre

Post

1 hour post

108

Appendix AA

109

Figure 4.17
Healthy Individual Subject’s Leptin Levels on VO2 Testing Day
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Note:. Comparisons here can be used to determine healthy individuals with a possibly
elevated risk for becoming obese. Line at 19.80 denotes mean Leptin levels at rest for the
obese group.
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Figure 4.18
Healthy individual subject’s pre, post, and 1-hour post CRP levels for the Wingate test
session
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Note: Comparisons here can be used to determine healthy individuals with a possibly
elevated risk for becoming obese. Line at 18.68 denotes mean Leptin levels for the obese
group at rest, which is being used for comparison.
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